TMCnet News
Research and Markets: MediPoint: Coronary Stents - Global Analysis and Market Forecasts to 2020 for the $5.6 Billion IndustryDUBLIN --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/8vr9nj/medipoint) has announced the addition of the "MediPoint: Coronary Stents - Global Analysis and Market Forecasts" report to their offering. Coronary Stent Sales by Region Coronary stents can be used for a wide range of indications in coronary artery disease (CAD), including de novo lesions, small-vessel disease (SVD), bifurcation lesions, and tortuous and narrow lesions. Coronary stents can improve the clinical outcomes for all of these indications as well as quality of life for patients suffering from this debilitating disease. In 2013, sales of DES and BMS in the 10MM were $4.89 billion. The authors estimates the 2014 sales of DES and BMS in the 10MM to be $4.99 billion. By 2020, sales of coronary stents, including bare metal and drug-eluting stents, will grow to $5.62 billion, at a Compound Annual Growth Rate (CAGR) of 2.0%. To date, BAS have not received regulatory approval and been launched in the US, Japanese, and Chinese markets, but are expected to enter these markets in the near future. Of the 10MM covered in the report, the US currently has and will continue to have the largest share in the coronary stents market. Together, the US, the 5EU countries, and Japan will account for 64% of the coronary stents market for BMS and DES in 2020. Collectively, the 5EU countries are forecast to have only 10% market hare in the future. Among the emerging markets, China has captured significant market share, which is expected to increase in the future. The emerging markets, including Brazil, China, and India, are expected to demonstrate the greatest growth in the market over the forecast period and will serve as an outlet of expansion for stent manufacturers to increase their global presence. The key drivers for the coronary stents market during the forecast period are:
Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Industry Overview 4 Unmet Needs 5 Market Opportunity Analysis 6 Market Drivers, Barriers, and Substitutes 7 Competitive Assessment 8 Pipeline Products 9 Clinical Trial Analysis 10 Current and Future Players 11 Market Outlook 12 Appendix Companies Mentioned
For more information visit http://www.researchandmarkets.com/research/8vr9nj/medipoint
|